Skip to main content
Log in

Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Pulsipher MA, Chitphakdithai P, Logan BR, Navarro WH, Levine JE, Miller JP et al. Lower risk of serious adverse events and no increased risk of cancer after PBSC versus bone marrow donation. Blood 2014; 123: 3655–3663.

    Article  CAS  Google Scholar 

  2. Barratt J, Feehally J . IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088–2097.

    Article  CAS  Google Scholar 

  3. McGrogan A, Franssen CFM, de Vries CS . The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2011; 26: 414–430.

    Article  Google Scholar 

  4. Funakoshi Y, Nazneen A, Nakashima Y, Nakashima K, Okada M, Taguchi T et al. The possible involvement of granulocyte-colony stimulating factor in IgA nephropathy which developed in a donor after undergoing allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2010; 45: 1477–1478.

    Article  CAS  Google Scholar 

  5. Woo KT, Chan CM, Chin YM, Choong HL, Tan HK, Foo M et al. Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract 2010; 116: c337–c346.

    Article  Google Scholar 

  6. Arora S, Bhargava A, Jasnosz K, Clark B . Relapsing acute kidney injury associated with pegfilgastrim. Case Rep Nephrol Urol 2012; 2: 165–171.

    Article  Google Scholar 

  7. Nasilowska-Adamska B, Perkowska-Ptasinska A, Tomaszewska A, Serwacka A, Marianska B . Acute glomerulonephritis in a donor as a side effect of allogeneic peripheral blood stem cell mobilization with granulocyte colony-stimulating factor. Int J Hematol 2010; 92: 765–768.

    Article  CAS  Google Scholar 

  8. Miller JP, Perry EH, Price TH, Bolan CD Jr, Karanes C, Boyd TM et al. Recovery and safety profiles of marrow and PBSC donors: experience of the national marrow donor program. Biol Blood Marrow Transplant 2008; 14: 29–36.

    Article  Google Scholar 

  9. WMDA. http://www.worldmarrow.org/fileadmin/Committees/SEAR/PRES/20120821-SEAR-Annual_Report_2011.pdf2011.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J B L Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J., Billen, A., Lown, R. et al. Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening. Bone Marrow Transplant 51, 286–287 (2016). https://doi.org/10.1038/bmt.2015.224

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.224

  • Springer Nature Limited

This article is cited by

Navigation